ClinicalTrials.gg
RecruitingNCT03834818COMPASUpdated May 5, 2026

Collecting Outcomes and Managing Pain After Surgery

An interventional study of COMPAS Participants in Surgery, sponsored by Duke University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-05-05.

Sponsored by Duke University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10,000
Allocation
Not applicable
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 51 studies in Pain by Duke University — 8 open to participants now, 8 under way, none of them phase 3. Pain · Duke University.

Planned enrollment
Largest of 46
10,000 · median 64
Started
2025
with 3 others
No phase
29 of 51
6 open now
Registered
23rd of 51
by date

Among the 51 studies in Pain by Duke University, this one has the largest planned enrollment of the 46 interventional ones that give a count, is one of 4 that started in 2025, is one of 29 with no phase, and was the 23rd registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

8 of the 51 studies in Pain by Duke University are open now, in 2 countries. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 51 studies in Pain by Duke University, or all of them as a file.
02

Study summary

The primary aim of this study is to measure pain and psychosocial patient reported outcomes, objective functionality, and actual daily at home opioid usage in orthopedic patients. The study's goal following the data collection is to predict which patients are at high risk for chronic opioid use.

03

Conditions studied

  • Surgery

Browse trials for

Keywords

  • opioid use
  • pain
  • surgery
  • orthopedic surgery
  • orthopedic
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged 18-90 years old who are undergoing elective orthopedic surgery at Duke Health.
  • Patients must have their own smartphone IOS or Android device.
  • Patients must be able to read English.

Exclusion criteria

Exclusion Criteria:

  • Lacking capacity to provide consent.
  • Cannot read English
  • Under 18 years of age
  • Older than 90 years of age
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10,000 participants (estimated)

Study arms

  • Experimental
    COMPAS Participants

    Patents between the ages of 18 and 90 who are undergoing orthopedic surgery at Duke Health will be eligible for enrollment.

    Behavioral: COMPAS Participants

Interventions

  • BehavioralCOMPAS Participants

    The schedule of events for this study are as follows: Day 1 Pre-Surgery: * Download the Medable App * Register to the study * Validated Questionnaires * Active Task Every Day * 9:00 a.m. Daily Questions * 9:00 p.m. Daily Questions Outcome Surveys and Active Task: * Day 1 Pre-Surgery * 1-Week Post Operation * 2-Weeks Post Operation * 1-Month Post Operation * 3-Months Post Operation * 6-Months Post Operation

06

What researchers measure

Primary outcomes

  1. Reported Pain of Participants measured via PROMIS-29

    28 Questions regarding pain are ranked on a 5-point Likert Scale with 1 meaning "not at all" and 5 meaning "very much".

    Time frame: 6 Months

  2. Reported Pain of Participants measured via PROMIS-29

    One question on an 11-point rating scale for pain intensity, with 0 meaning "no pain" and 10 meaning "worst imaginable pain".

    Time frame: 6 Months

  3. Reported Pain of Participants measured via Pain Catastrophizing pain scale.

    Statements regarding pain are rated on a scale from 0 to 4 with 0 meaning "not at all" and 4 meaning "all the time"

    Time frame: 6 Months

  4. Opioid Use of Participants

    Total number of patients with self reported use of opioids.

    Time frame: 6 months

  5. Practicality of Mobile Application

    How long participants actively use the app to track their opined use and pain.

    Time frame: 6 Months

07

Study locations

1 of 1 sites recruiting
  • Duke Orthopaedics
    Durham, North Carolina 27710, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Apr 2028, 39 months after the start.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 39 months is above that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2019
First posted
Feb 8, 2019
StartActual
Jan 13, 2025
Primary completionEst.
Apr 2028
CompletionEst.
Apr 2028
Last update
May 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03834818
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Feb 8, 2019
Start date
Jan 13, 2025
Primary completion
Apr 2028 (estimated)
Completion
Apr 2028 (estimated)
Last update
May 5, 2026

Study contacts

Ashley Burke
Contact
ashley.burke@duke.edu
+1 919 681 2849
Michael Bullock, MD
Contact
william.bullock@duke.edu
+1 919 668 2024
Michael Bullock, MD
principal investigator · Duke University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion